USP Monographs Will Follow International Format For Drug Impurities
A new format for active pharmaceutical ingredient monographs will provide a more consistent approach to identify impurities, U.S. Pharmacopeia VP-Information & Standards Development Eric Sheinin, PhD, said
You may also be interested in...
FDA is considering undertaking a broad guidance clean-up effort, agency Chief Counsel Daniel Troy indicated May 16 during a Generic Pharmaceutical Association legal symposium in Washington, D.C
Gender analysis is a required component of FDA's newly instituted standardized format for NDA reviews, the agency said April 18.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011